| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:04:34 UTC |
|---|
| Update date | 2020-09-17 15:41:41 UTC |
|---|
| Primary ID | FDB000455 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Theobromine |
|---|
| Description | Theobromine, also known as diurobromine, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Theobromine is an extremely weak basic (essentially neutral) compound (based on its pKa). Theobromine is an isomer of theophylline, as well as paraxanthine. Theobromine exists in all living organisms, ranging from bacteria to humans. Within humans, theobromine participates in a number of enzymatic reactions. In particular, theobromine and formaldehyde can be biosynthesized from caffeine through the action of the enzymes cytochrome P450 1A2 and cytochrome P450 2E1. In addition, theobromine can be converted into 3,7-dimethyluric acid through its interaction with the enzyme xanthine dehydrogenase/oxidase. In humans, theobromine is involved in caffeine metabolism. Theobromine is a bitter tasting compound. Outside of the human body, Theobromine is found, on average, in the highest concentration within a few different foods, such as cocoa powders, chocolates, and cocoa beans and in a lower concentration in other candies, cakes, and soy milks. Theobromine has also been detected, but not quantified in, several different foods, such as hyacinth beans, oyster mushrooms, tamarinds, milk (other mammals), and watercress. This could make theobromine a potential biomarker for the consumption of these foods. Theobromine and caffeine are similar in that they are related alkaloids. A necropsy and toxicology report performed at the University of New Hampshire in 2015 confirmed they died of heart failure caused by theobromine after they consumed 41 kilograms (90 lb) of chocolate and doughnuts placed at the site as bait. |
|---|
| CAS Number | 83-67-0 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 3,7-Dihydro-3,7-dimethyl-1H-purine-2,6-dione | ChEBI | | 3,7-Dimethylpurine-2,6-dione | ChEBI | | 3,7-Dimethylxanthine | ChEBI | | Theobromin | ChEBI | | Teobromin | HMDB | | 2,6-Dihydroxy-3,7-dimethyl-purine | HMDB | | 3,7-Dimethyl-xanthine | HMDB | | Diurobromine | HMDB | | 1H-Purine-2,6-dione, 3, 7-dihydro-3,7-dimethyl- | biospider | | 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl- | biospider | | 1H-purine-2,6-dione,3,7-dihydro-3,7- dimethyl- (9CI) | biospider | | 2,6-Dihydroxy-3,7-dimethylpurine | biospider | | 3-7-DIMETHYLXANTHINE | biospider | | 3,7-Dihydro-3,7-dimethyl-1H-purine-2,6-dione, 9CI | db_source | | 3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione | biospider | | 3,7-dimethylpurine-2,6-dione | biospider | | FEMA 3591 | db_source | | Santheose | db_source | | Theobromine [ban] | biospider | | Theobrominum | biospider | | Theosalvose | biospider | | Theostene | biospider | | Thesal | db_source | | Thesodate | biospider | | Xanthine, 3,7-dimethyl- | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C7H8N4O2 |
|---|
| IUPAC name | 3,7-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione |
|---|
| InChI Identifier | InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13) |
|---|
| InChI Key | YAPQBXQYLJRXSA-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | CN1C=NC2=C1C(=O)NC(=O)N2C |
|---|
| Average Molecular Weight | 180.164 |
|---|
| Monoisotopic Molecular Weight | 180.06472552 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Imidazopyrimidines |
|---|
| Sub Class | Purines and purine derivatives |
|---|
| Direct Parent | Xanthines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Xanthine
- 6-oxopurine
- Purinone
- Alkaloid or derivatives
- Pyrimidone
- N-substituted imidazole
- Pyrimidine
- Azole
- Imidazole
- Heteroaromatic compound
- Vinylogous amide
- Lactam
- Urea
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Process | Naturally occurring process: |
|---|
| Role | Industrial application: Biological role: |
|---|
| Foods | Cocoa and cocoa products Beverages: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 46.67%; H 4.48%; N 31.10%; O 17.76% | DFC |
|---|
| Melting Point | Mp 351° | DFC |
|---|
| Boiling Point | Subl. 290° | DFC |
|---|
| Experimental Water Solubility | 0.33 mg/mL at 25 oC | YALKOWSKY,SH & HE,Y (2003) |
|---|
| Experimental logP | -0.78 | HANSCH,C ET AL. (1995) |
|---|
| Experimental pKa | pKa2 10 (25°) | DFC |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-001i-9700000000-770b2dc556ada7d97cae | 2015-03-01 | View Spectrum | | GC-MS | Theobromine, 1 TMS, GC-MS Spectrum | splash10-0079-7980000000-efb14ee11aad17b6b4d2 | Spectrum | | GC-MS | Theobromine, non-derivatized, GC-MS Spectrum | splash10-001i-6900000000-7d44855bbf11e559d96e | Spectrum | | GC-MS | Theobromine, non-derivatized, GC-MS Spectrum | splash10-0079-7980000000-efb14ee11aad17b6b4d2 | Spectrum | | Predicted GC-MS | Theobromine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0zgr-0900000000-87a73eda89d8ce593ee8 | Spectrum | | Predicted GC-MS | Theobromine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-001i-0900000000-8d639c53ad9b2b8f508e | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-014i-9300000000-0d20b5fe9b93b113a29e | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-014l-9000000000-55968ca3e94ce5a05cfe | 2012-07-25 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - EI-B (Unknown) , Positive | splash10-001i-6900000000-7d44855bbf11e559d96e | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-001i-1900000000-1932568f11357ae32f55 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-001i-2900000000-3918185c5a4afb18f11a | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-0910-5900000000-b590772083f824ea0fc6 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-014i-9400000000-c06ac99fd6e0c84d9653 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-014i-9100000000-3802e577174b5a4acced | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - DI-ESI-qTof , Positive | splash10-02a9-2900000400-2ae0058f4f5f9fc23c01 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , negative | splash10-004j-7900000000-54365e34320abc3c8f2e | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-001i-1900000000-599d34de0bc963388dc0 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-001i-2900000000-8a0fd0cd87c35684d19f | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-0910-5900000000-b590772083f824ea0fc6 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-014i-9400000000-c06ac99fd6e0c84d9653 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , positive | splash10-014i-9100000000-3802e577174b5a4acced | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-001i-0900000000-b1202b5f491f2aaaf542 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-01qi-0900000000-d58a783853c528b7d126 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-01b9-8900000000-d9e4a4411ab0ed3620a0 | 2017-09-14 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-001i-0900000000-3f82b9da0450b7ae12ae | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-001i-0900000000-235bf01d7d7435b9fe54 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0kai-9200000000-cb89e2e8ee405aba807d | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0900000000-fa072bef954a047da7f7 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004r-0900000000-22f6a3f6049c3a993878 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-052f-9300000000-afa55dfa675c3caec4f0 | 2017-06-28 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, 100%_DMSO, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, DMSO, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, DMSO, experimental) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 100%_DMSO, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 5236 |
|---|
| ChEMBL ID | CHEMBL1114 |
|---|
| KEGG Compound ID | C07480 |
|---|
| Pubchem Compound ID | 5429 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 28946 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB01412 |
|---|
| HMDB ID | HMDB02825 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | BCL39-R:BCL39-R |
|---|
| EAFUS ID | 3651 |
|---|
| Dr. Duke ID | THEOBROMINE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00001509 |
|---|
| HET ID | 37T |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Theobromine |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anorexic | 50780 | An agent that suppresses appetite, reducing food intake. Its biological role involves regulating hunger and satiety signals. Therapeutically, anorexics are used to treat obesity and weight-related disorders, promoting weight loss and improving metabolic health. Key medical uses include managing exogenous obesity and related conditions, such as diabetes and hypertension. | DUKE | | Anti-asthmatic | 49167 | An agent that relieves bronchospasm and inflammation, commonly used to manage asthma symptoms, chronic obstructive pulmonary disease (COPD), and other respiratory disorders, improving lung function and overall respiratory health. | DUKE | | Anti cellulitic | 52217 | An agent that reduces the appearance of cellulite, improving skin texture and tone. It enhances blood flow, breaks down fat cells, and strengthens connective tissue, commonly used in cosmetic and dermatological treatments to minimize dimpling and orange peel skin. | DUKE | | Arteriodilator | | An agent that dilates arteries, increasing blood flow to or from the heart, used therapeutically to manage conditions like hypertension, heart failure, and angina, improving cardiac output and reducing blood pressure. | DUKE | | Bronchodilator | 35523 | An agent that relaxes airway muscles, increasing airflow to the lungs. It reduces bronchospasm, commonly used in managing asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders to improve breathing and relieve symptoms. | DUKE | | cAMP inhibitor | 35222 | An agent that blocks the activity of cyclic adenosine monophosphate (cAMP), a key signaling molecule. It reduces intracellular cAMP levels, modulating various biological processes. Therapeutically, cAMP inhibitors are used to treat conditions like asthma, cancer, and cardiovascular diseases by regulating cell signaling pathways and inflammation. | DUKE | | cAMP-phosphodiesterase inhibitor | 23924 | An agent that blocks the breakdown of cyclic adenosine monophosphate (cAMP), increasing its levels and enhancing cellular signaling. Therapeutically, it is used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), as well as certain cardiovascular conditions. | DUKE | | Cardiotonic | 38070 | An agent that strengthens heart muscle contractions, enhancing cardiac output. It plays a biological role in regulating heart function and is therapeutically used to treat heart failure, improving symptoms and exercise tolerance. Key medical uses include managing cardiomyopathy, atrial fibrillation, and congestive heart failure. | DUKE | | cGMP-phosphodiesterase inhibitor | 23924 | An agent that blocks the breakdown of cyclic guanosine monophosphate (cGMP), increasing its levels. It relaxes smooth muscle, dilates blood vessels, and improves cardiac function. Therapeutically used to treat erectile dysfunction, pulmonary hypertension, and heart failure, improving exercise tolerance and quality of life. | DUKE | | Central nervous system stimulant | 35470 | An agent that increases alertness and activity by enhancing neurotransmitter release, used therapeutically to manage attention deficit hyperactivity disorder (ADHD), narcolepsy, and fatigue, and to improve cognitive function and mood. | DUKE | | Diuretic | 35498 | An agent that increases urine production, helping remove excess fluids and salts from the body. It plays a key biological role in regulating fluid balance and blood pressure. Therapeutically, diuretics are used to treat conditions such as hypertension, edema, and heart failure, helping reduce swelling and lower blood pressure. | DUKE | | Emetic | | An agent that induces vomiting, playing a biological role in expelling toxins from the body. Therapeutically, it is used to treat poisoning, overdose, or gastrointestinal obstruction. Key medical uses include managing drug toxicity and aiding in stomach pumping procedures. | DUKE | | Fetotoxic | 52209 | An agent that is toxic to the fetus, causing harm or developmental issues during pregnancy. Its biological role is to induce fetal damage, and it has no therapeutic applications. Key medical uses include serving as a warning or contraindication for certain medications or substances during pregnancy to prevent fetal harm. | DUKE | | Herbicide | 24527 | A chemical agent that kills or inhibits plant growth, used in agriculture to control weeds and pests. It has no direct biological role or therapeutic applications in human medicine, but its development has led to the creation of related compounds with potential medical uses, such as anticancer agents. | DUKE | | Myocardiotonic | 38070 | An agent that strengthens heart muscle contractions, enhancing cardiac function. It plays a biological role in increasing cardiac output and reducing symptoms of heart failure. Therapeutically, myocardiotonics are used to manage conditions like cardiomyopathy, heart failure, and coronary artery disease, improving overall cardiac performance. | DUKE | | Myorelaxant | | An agent that reduces muscle contractility by blocking nerve impulses or decreasing motor end plate excitability, used therapeutically to relieve muscle spasms, tension, and pain, commonly in managing musculoskeletal disorders, anxiety, and insomnia. | DUKE | | Myostimulant | | An agent that stimulates an increase in the rhythm and amplitude of smooth muscle movement, playing a biological role in enhancing muscle contraction. Therapeutically, it is used to treat gastrointestinal disorders, such as constipation, and other conditions characterized by reduced muscle activity, like urinary retention. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Stimulant | | An agent that enhances alertness, wakefulness, and physical activity by increasing brain activity. Therapeutically, it is used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy, and certain cases of depression, improving focus, attention, and overall mental performance. | DUKE | | Teratogenic | 50905 | An agent that causes abnormal fetal development, disrupting embryonic growth and leading to birth defects. Its biological role is associated with developmental toxicity, and it has no therapeutic applications. Key medical uses include serving as a warning for substances that pose risks during pregnancy, guiding prenatal care and medication management to prevent birth defects. | DUKE | | Vasodilator | 35620 | An agent that widens blood vessels, reducing blood pressure and increasing blood flow. It plays a biological role in regulating cardiovascular function. Therapeutically, vasodilators are used to treat conditions such as hypertension, angina, and heart failure, improving oxygen delivery and reducing cardiac workload. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Adenosine receptor A1 | ADORA1 | P30542 | | Adenosine receptor A2a | ADORA2A | P29274 |
|
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| bitter |
- Ayana Wiener, Marina Shudler, Anat Levit, Masha Y. Niv. BitterDB: a database of bitter compounds. Nucleic Acids Res 2012, 40(Database issue):D413-419. DOI:10.1093/nar/gkr755
|
|
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — U.S. Department of Agriculture, Agricultural Research Service. 2008. USDA National Nutrient Database for Standard Reference, Release 21. Nutrient Data Laboratory Home Page. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|